Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 103

Similar articles for PubMed (Select 12149457)

1.

Enzyme activity profiles of the secreted and membrane proteome that depict cancer cell invasiveness.

Jessani N, Liu Y, Humphrey M, Cravatt BF.

Proc Natl Acad Sci U S A. 2002 Aug 6;99(16):10335-40. Epub 2002 Jul 29.

2.

Carcinoma and stromal enzyme activity profiles associated with breast tumor growth in vivo.

Jessani N, Humphrey M, McDonald WH, Niessen S, Masuda K, Gangadharan B, Yates JR 3rd, Mueller BM, Cravatt BF.

Proc Natl Acad Sci U S A. 2004 Sep 21;101(38):13756-61. Epub 2004 Sep 8.

3.

Profiling serine hydrolase activities in complex proteomes.

Kidd D, Liu Y, Cravatt BF.

Biochemistry. 2001 Apr 3;40(13):4005-15.

PMID:
11300781
4.
5.

Colon tumour secretopeptidome: insights into endogenous proteolytic cleavage events in the colon tumour microenvironment.

Greening DW, Kapp EA, Ji H, Speed TP, Simpson RJ.

Biochim Biophys Acta. 2013 Nov;1834(11):2396-407. doi: 10.1016/j.bbapap.2013.05.006. Epub 2013 May 15.

PMID:
23684732
6.

Liver membrane proteome glycosylation changes in mice bearing an extra-hepatic tumor.

Lee A, Chick JM, Kolarich D, Haynes PA, Robertson GR, Tsoli M, Jankova L, Clarke SJ, Packer NH, Baker MS.

Mol Cell Proteomics. 2011 Sep;10(9):M900538MCP200. doi: 10.1074/mcp.M900538-MCP200. Epub 2010 Feb 18.

7.
8.

A potential marker protease of invasiveness, seprase, is localized on invadopodia of human malignant melanoma cells.

Monsky WL, Lin CY, Aoyama A, Kelly T, Akiyama SK, Mueller SC, Chen WT.

Cancer Res. 1994 Nov 1;54(21):5702-10.

9.
10.

High levels of γ-glutamyl hydrolase (GGH) are associated with poor prognosis and unfavorable clinical outcomes in invasive breast cancer.

Shubbar E, Helou K, Kovács A, Nemes S, Hajizadeh S, Enerbäck C, Einbeigi Z.

BMC Cancer. 2013 Feb 1;13:47. doi: 10.1186/1471-2407-13-47.

11.

Identification of differentially secreted biomarkers using LC-MS/MS in isogenic cell lines representing a progression of breast cancer.

Mbeunkui F, Metge BJ, Shevde LA, Pannell LK.

J Proteome Res. 2007 Aug;6(8):2993-3002. Epub 2007 Jul 4.

12.

Plasma membrane proteomics and its application in clinical cancer biomarker discovery.

Leth-Larsen R, Lund RR, Ditzel HJ.

Mol Cell Proteomics. 2010 Jul;9(7):1369-82. doi: 10.1074/mcp.R900006-MCP200. Epub 2010 Apr 8. Review.

13.

A streamlined platform for high-content functional proteomics of primary human specimens.

Jessani N, Niessen S, Wei BQ, Nicolau M, Humphrey M, Ji Y, Han W, Noh DY, Yates JR 3rd, Jeffrey SS, Cravatt BF.

Nat Methods. 2005 Sep;2(9):691-7.

PMID:
16118640
14.

Large isoform of MRJ (DNAJB6) reduces malignant activity of breast cancer.

Mitra A, Fillmore RA, Metge BJ, Rajesh M, Xi Y, King J, Ju J, Pannell L, Shevde LA, Samant RS.

Breast Cancer Res. 2008;10(2):R22. doi: 10.1186/bcr1874. Epub 2008 Mar 7.

15.

Regulation of motility and protease expression in PKC-mediated induction of MCF-7 breast cancer cell invasiveness.

Johnson MD, Torri JA, Lippman ME, Dickson RB.

Exp Cell Res. 1999 Feb 25;247(1):105-13.

PMID:
10047452
16.

Metadegradomics: toward in vivo quantitative degradomics of proteolytic post-translational modifications of the cancer proteome.

Doucet A, Butler GS, Rodríguez D, Prudova A, Overall CM.

Mol Cell Proteomics. 2008 Oct;7(10):1925-51. doi: 10.1074/mcp.R800012-MCP200. Epub 2008 Jul 2. Review.

17.

Fibroblast activation protein-α promotes tumor growth and invasion of breast cancer cells through non-enzymatic functions.

Huang Y, Simms AE, Mazur A, Wang S, León NR, Jones B, Aziz N, Kelly T.

Clin Exp Metastasis. 2011 Aug;28(6):567-79. doi: 10.1007/s10585-011-9392-x. Epub 2011 May 22.

PMID:
21604185
18.

Secretomic and proteomic analysis of potential breast cancer markers by two-dimensional differential gel electrophoresis.

Lai TC, Chou HC, Chen YW, Lee TR, Chan HT, Shen HH, Lee WT, Lin ST, Lu YC, Wu CL, Chan HL.

J Proteome Res. 2010 Mar 5;9(3):1302-22. doi: 10.1021/pr900825t.

PMID:
20052998
19.

Membrane proteases as potential diagnostic and therapeutic targets for breast malignancy.

Chen WT, Lee CC, Goldstein L, Bernier S, Liu CH, Lin CY, Yeh Y, Monsky WL, Kelly T, Dai M, et al.

Breast Cancer Res Treat. 1994;31(2-3):217-26. Review.

PMID:
7881100
20.

Identification of the 170-kDa melanoma membrane-bound gelatinase (seprase) as a serine integral membrane protease.

Piñeiro-Sánchez ML, Goldstein LA, Dodt J, Howard L, Yeh Y, Tran H, Argraves WS, Chen WT.

J Biol Chem. 1997 Mar 21;272(12):7595-601. Erratum in: J Biol Chem. 1998 May 22:273(21):13366.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk